Evolent Health (EVH) Intangibles (2015 - 2026)

Evolent Health's Intangibles history runs 12 years deep, the most recent figure standing at $569.7 million for Q1 2026.

• On a quarterly basis, Intangibles fell 14.7% year-over-year to $569.7 million in Q1 2026; TTM through Mar 2026 was $569.7 million, a 14.7% decrease from a year earlier, with the FY2025 full-year figure at $584.9 million, down 14.0% from the prior year.
• Intangibles retreated to $569.7 million in Q1 2026 per EVH's latest filing, from $584.9 million in the prior quarter.
• Across five years, Intangibles topped out at $825.9 million in Q1 2023 and bottomed at $264.8 million in Q2 2022.
• The 5-year median for Intangibles is $667.9 million (2025), against an average of $618.0 million.
• Across the five-year window, Intangibles surged 203.39% in 2023 and slipped 14.7% in 2026, its largest moves.
• Year by year, Intangibles stood at $442.8 million in 2022, then soared by 69.84% to $752.0 million in 2023, then declined by 9.55% to $680.2 million in 2024, then decreased by 14.0% to $584.9 million in 2025, then slipped by 2.61% to $569.7 million in 2026.
• Per Business Quant, the three latest EVH Intangibles figures stand at $569.7 million (Q1 2026), $584.9 million (Q4 2025), and $623.7 million (Q3 2025).